Implant Sciences Receives First Order From GSA Schedule Contract
WAKEFIELD, Mass.--(BUSINESS WIRE)--Implant Sciences Corporation (AMEX: IMX), a high technology supplier of sophisticated systems and sensors for the homeland security market and related industries, today announced it has received its first order purchased through its recently awarded General Services Administration (GSA) Schedule Contract. The order, from a component of the Department of Defense, is for two (2) of the Company's Quantum Sniffer™ QS-H150 Portable Explosives Detectors.
"Receiving our first order from the GSA schedule less than two weeks after contract award is a rewarding culmination of our team's efforts. We are enthusiastic about the additional sales opportunities that the GSA contract award has made possible from a wide range of federal, state, and local government agencies and their affiliates," said Richard Meyerhoff, VP of Worldwide Sales and Service for Implant Sciences Corp.
The QS-H150 provides high performance and reliability combined with a very low comparative cost of ownership. Annual maintenance costs are minimal and consist primarily of normal care and cleaning using common, low cost supplies. Calibration is autonomous, continuous, and requires no consumables. Since there are no radioactive materials used in the QS-H150, there are no associated certifications, licenses, inspections, or end-of-life disposal issues for users to contend with. As such, customers have an outstanding, cost effective product available to them in support of efforts to improve their overall security profile and meet mission critical objectives.
About Implant Sciences
Implant Sciences develops, manufactures and sells sophisticated sensors and systems for the Security, Safety and Defense (SS&D) industries. The Company has developed proprietary technologies used in its commercial portable and bench-top explosive trace detection systems which ship to a growing number of locations domestically and internationally. For further details on the Company and its products, please visit the Company's website at www.implantsciences.com.
Safe Harbor Statement
This press release contains certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the Company's ability to successfully sell its QS-H150 products to government agencies authorized to procure goods and services from the GSA schedule, the inability of the Company to expand and strengthen its governmental distribution channel, the risk that the Company will not realize the anticipated benefits of the GSA schedule, and other risks and uncertainties described in the Company's filings with the Securities and Exchange Commission, including its most recent Forms 10-K, 10-Q and 8-K.
For further information, you are encouraged to review Implant Sciences' filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the period ended June 30, 2007 and Quarterly Reports for the periods ended September 30, 2007, December 31, 2007 and March 31, 2008. The Company assumes no obligation to update the information contained in this press release
Copyright 2008 Business Wire All Rights Reserved